|
1.CDC, American National Health and Nutrition Examination Survey. 2014.
2.Hill, N.R., et al., Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One, 2016. 11(7): p. e0158765.
3.衛生福利部, 104年死因統計結果分析. 2016.
4.USRDS, 2015 USRDS Annual Data Report. 2015.
5.Yang, M., et al., Complications of progression of CKD. Adv Chronic Kidney Dis, 2011. 18(6): p. 400-5.
6.Blaine, J., M. Chonchol, and M. Levi, Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol, 2015. 10(7): p. 1257-72.
7.Koeppen, B.M., Renal Regulation of Acid-Base Balance. Am J Kidney Dis, 1998. 20: p. 132-141.
8.Al-Mutairi, N., B.I. Issa, and V. Nair, Photoprotection and vitamin D status: a study on awareness, knowledge and attitude towards sun protection in general population from Kuwait, and its relation with vitamin D levels. Indian J Dermatol Venereol Leprol, 2012. 78(3): p. 342-9.
9.Erslev, A.J. and A. Besarab, Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure. Kidney Int, 1997. 51(3): p. 622-30.
10.Rossier, B.C., Hypertension finds a new rhythm. Nat Med, 2010. 16(1): p. 27-8.
11.Triplitt, C.L., Understanding the kidneys' role in blood glucose regulation. Am J Manag Care, 2012. 18(1 Suppl): p. S11-6.
12.Wong, E., Chronic kidney disease (CKD) Sultan Chaudhry. The New England Journal of Medicine, 2012. 14: p. 165-80.
13.Song, E.Y., et al., Effect of community characteristics on familial clustering of end-stage renal disease. Am J Nephrol, 2009. 30(6): p. 499-504.
14.Neugarten, J., A. Acharya, and S.R. Silbiger, Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol, 2000. 11(2): p. 319-29.
15.Iseki, K., Factors influencing the development of end-stage renal disease. Clin Exp Nephrol, 2005. 9(1): p. 5-14.
16.Epstein, M., Aging and the kidney. J Am Soc Nephrol, 1996. 7(8): p. 1106-22.
17.Barigye, O., Smoking and Inflammation. PLOS Medicine, 2005. 2(6): p. e198.
18.Orth, S.R., et al., Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant, 2005. 20(11): p. 2414-9.
19.Nasri, H. and M. Rafieian-Kopaei, Diabetes mellitus and renal failure: Prevention and management. J Res Med Sci, 2015. 20(11): p. 1112-20.
20.Klag, M.J., et al., Blood pressure and end-stage renal disease in men. N Engl J Med, 1996. 334(1): p. 13-8.
21.Kasiske, B.L., et al., A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis, 1998. 31(6): p. 954-61.
22.Fouque, D. and M. Laville, Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database Syst Rev, 2009(3): p. Cd001892.
23.財團法人國家衛生研究院, 2015臺灣慢性腎臟病臨床診療指引專書. 2015.
24.Maschio, G., et al., Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med, 1996. 334(15): p. 939-45.
25.Strippoli, G.F., et al., Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev, 2006(4): p. Cd006257.
26.衛生福利部, 2014 臺灣腎病年報. 2014.
27.Goldstein, R.S., J.B. Tarloff, and J.B. Hook, Age-related nephropathy in laboratory rats. Faseb j, 1988. 2(7): p. 2241-51.
28.Dickie, P., et al., HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology, 1991. 185(1): p. 109-19.
29.Yang, H.-C., Y. Zuo, and A.B. Fogo, Models of chronic kidney disease. Drug Discovery Today: Disease Models, 2010. 7(1): p. 13-19.
30.Zegers-Hochschild, F., et al., International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril, 2009. 92(5): p. 1520-4.
31.Mascarenhas, M.N., et al., National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med, 2012. 9(12): p. e1001356.
32.Direkvand-Moghadam, A., et al., The global trend of infertility: an original review and meta-analysis. International Journal of Epidemiologic Research, 2014. 1(1): p. 35-43.
33.Agarwal, A., et al., A unique view on male infertility around the globe. Reprod Biol Endocrinol, 2015. 13: p. 37.
34.Jose-Miller, A.B., J.W. Boyden, and K.A. Frey, Infertility. Am Fam Physician, 2007. 75(6): p. 849-56.
35.Olayemi, F.O., A review on some causes of male infertility. African Journal of Biotechnology, 2010. 9(20): p. 2834-2842.
36.Baazeem, A., et al., Varicocele and male factor infertility treatment: a new meta-analysis and review of the role of varicocele repair. Eur Urol, 2011. 60(4): p. 796-808.
37.Ley, S.B. and J.M. Leonard, Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens. J Clin Endocrinol Metab, 1985. 61(4): p. 746-52.
38.Garolla, A., et al., Oral carnitine supplementation increases sperm motility in asthenozoospermic men with normal sperm phospholipid hydroperoxide glutathione peroxidase levels. Fertil Steril, 2005. 83(2): p. 355-61.
39.Safarinejad, M.R., Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men. J Urol, 2009. 182(1): p. 237-48.
40.Akmal, M., et al., Improvement in human semen quality after oral supplementation of vitamin C. J Med Food, 2006. 9(3): p. 440-2.
41.Keskes-Ammar, L., et al., Sperm oxidative stress and the effect of an oral vitamin E and selenium supplement on semen quality in infertile men. Arch Androl, 2003. 49(2): p. 83-94.
42.Shalet, S.M., Normal testicular function and spermatogenesis. Pediatr Blood Cancer, 2009. 53(2): p. 285-8.
43.Stojkov, N.J., et al., Sustained in vivo blockade of alpha(1)-adrenergic receptors prevented some of stress-triggered effects on steroidogenic machinery in Leydig cells. Am J Physiol Endocrinol Metab, 2013. 305(2): p. E194-204.
44.Valenti, D., et al., Follicle-stimulating hormone treatment in normogonadotropic infertile men. Nat Rev Urol, 2013. 10(1): p. 55-62.
45.Bachman, E., et al., Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. J Gerontol A Biol Sci Med Sci, 2014. 69(6): p. 725-35.
46.Griggs, R.C., et al., Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol (1985), 1989. 66(1): p. 498-503.
47.Roth, M.Y., J.K. Amory, and S.T. Page, Treatment of male infertility secondary to morbid obesity. Nat Clin Pract Endocrinol Metab, 2008. 4(7): p. 415-9.
48.Koeppen, B.M. and B.A. Stanton, Berne & Levy Physiology, 6th Updated Edition. 2010.
49.Kapoor, D., et al., Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care, 2007. 30(4): p. 911-7.
50.Hermo, L., et al., Surfing the wave, cycle, life history, and genes/proteins expressed by testicular germ cells. Part 1: background to spermatogenesis, spermatogonia, and spermatocytes. Microsc Res Tech, 2010. 73(4): p. 241-78.
51.Heller, C.G. and Y. Clermont, Spermatogenesis in man: an estimate of its duration. Science, 1963. 140(3563): p. 184-6.
52.Creasy, D.M., Evaluation of testicular toxicity in safety evaluation studies: the appropriate use of spermatogenic staging. Toxicol Pathol, 1997. 25(2): p. 119-31.
53.Neto, F.T., et al., Spermatogenesis in humans and its affecting factors. Semin Cell Dev Biol, 2016. 59: p. 10-26.
54.Hogarth, C.A. and M.D. Griswold, The key role of vitamin A in spermatogenesis. J Clin Invest, 2010. 120(4): p. 956-62.
55.Holdcraft, R.W. and R.E. Braun, Hormonal regulation of spermatogenesis. Int J Androl, 2004. 27(6): p. 335-42.
56.Wong, W.Y., et al., Male factor subfertility: possible causes and the impact of nutritional factors. Fertil Steril, 2000. 73(3): p. 435-42.
57.Omu, A.E., et al., Molecular basis for the effects of zinc deficiency on spermatogenesis: An experimental study in the Sprague-dawley rat model. Indian J Urol, 2015. 31(1): p. 57-64.
58.Behne, D., H. Weiler, and A. Kyriakopoulos, Effects of selenium deficiency on testicular morphology and function in rats. J Reprod Fertil, 1996. 106(2): p. 291-7.
59.Seminara, S.B., et al., Genetics of hypogonadotropic hypogonadism. J Endocrinol Invest, 2000. 23(9): p. 560-5.
60.Babitt, J.L. and H.Y. Lin, Mechanisms of Anemia in CKD. J Am Soc Nephrol, 2012. 23(10): p. 1631-4.
61.Arnold, R., et al., Neurological complications in chronic kidney disease. JRSM Cardiovasc Dis, 2016. 5: p. 2048004016677687.
62.Iglesias, P., J.J. Carrero, and J.J. Diez, Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options. J Nephrol, 2012. 25(1): p. 31-42.
63.Handelsman, D.J. and P.Y. Liu, Androgen therapy in chronic renal failure. Baillieres Clin Endocrinol Metab, 1998. 12(3): p. 485-500.
64.Khurana, K.K., et al., Serum testosterone levels and mortality in men with CKD stages 3-4. Am J Kidney Dis, 2014. 64(3): p. 367-74.
65.Carrero, J.J., et al., Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease. Nephrol Dial Transplant, 2011. 26(1): p. 184-90.
66.Bello, A.K., et al., Serum testosterone levels and clinical outcomes in male hemodialysis patients. Am J Kidney Dis, 2014. 63(2): p. 268-75.
67.Rodriguez-Acuna, R., E. Brenne, and F. Lacoste, Determination of coenzyme Q10 and Q9 in vegetable oils. J Agric Food Chem, 2008. 56(15): p. 6241-5.
68.Tran, M.T., et al., Role of coenzyme Q10 in chronic heart failure, angina, and hypertension. Pharmacotherapy, 2001. 21(7): p. 797-806.
69.BOREKOVÁ, M., et al., Nourishing and Health Benefits of Coenzyme Q10 -a review. Czech J. Food Sci., 2008. 26(4): p. 229–241.
70.Chow, C.K., Dietary coenzyme Q10 and mitochondrial status. Methods in Enzymology, 2004. 382: p. 105-112.
71.Ernster, L. and G. Dallner, Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta, 1995. 1271(1): p. 195-204.
72.Bhagavan, H.N. and R.K. Chopra, Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res, 2006. 40(5): p. 445-53.
73.Lenaz, G., et al., The function of coenzyme Q in mitochondria. Clin Investig, 1993. 71(8 Suppl): p. S66-70.
74.Al Ghouleh, I., et al., Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling. Free Radic Biol Med, 2011. 51(7): p. 1271-88.
75.Kalen, A., et al., Nonaprenyl-4-hydroxybenzoate transferase, an enzyme involved in ubiquinone biosynthesis, in the endoplasmic reticulum-Golgi system of rat liver. J Biol Chem, 1990. 265(2): p. 1158-64.
76.Ernster, L. and P. Forsmark-Andree, Ubiquinol: an endogenous antioxidant in aerobic organisms. Clin Investig, 1993. 71(8 Suppl): p. S60-5.
77.Benit, P. and P. Rustin, Changing the diet to make more mitochondria and protect the heart. Circ Res, 2012. 110(8): p. 1047-8.
78.Cordero, M.D., et al., Can coenzyme q10 improve clinical and molecular parameters in fibromyalgia? Antioxid Redox Signal, 2013. 19(12): p. 1356-61.
79.Hargreaves, I.P., Coenzyme Q10 as a therapy for mitochondrial disease. Int J Biochem Cell Biol, 2014. 49: p. 105-11.
80.Himmelfarb, J. and R.M. Hakim, Oxidative stress in uremia. Curr Opin Nephrol Hypertens, 2003. 12(6): p. 593-8.
81.Yeung, C.K., et al., Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress. BMC Nephrol, 2015. 16: p. 183.
82.Behling, E.B., et al., Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys. Pharmacol Rep, 2006. 58(4): p. 526-32.
83.Locatelli, F., et al., Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant, 2003. 18(7): p. 1272-80.
84.Schmelzer, C., et al., Effects of Coenzyme Q10 on TNF-alpha secretion in human and murine monocytic cell lines. Biofactors, 2007. 31(1): p. 35-41.
85.Upaganlawar, A., et al., Modification of biochemical parameters of gentamicin nephrotoxicity by coenzyme Q10 and green tea in rats. Indian J Exp Biol, 2006. 44(5): p. 416-8.
86.Fouad, A.A., et al., Coenzyme Q10 treatment ameliorates acute cisplatin nephrotoxicity in mice. Toxicology, 2010. 274(1-3): p. 49-56.
87.Desai, N., et al., Free radical theory of aging: implications in male infertility. Urology, 2010. 75(1): p. 14-9.
88.Aitken, R.J., J.S. Clarkson, and S. Fishel, Generation of reactive oxygen species, lipid peroxidation, and human sperm function. Biol Reprod, 1989. 41(1): p. 183-97.
89.Showell, M.G., et al., Antioxidants for male subfertility. Cochrane Database Syst Rev, 2011(1): p. Cd007411.
90.Sheweita, S.A., A.M. Tilmisany, and H. Al-Sawaf, Mechanisms of male infertility: role of antioxidants. Curr Drug Metab, 2005. 6(5): p. 495-501.
91.Bykova, M., et al., Defining the reference value of seminal reactive oxygen species in a population of infertile men and normal healthy volunteers. Fertility and Sterility, 2007. 88, Supplement 1: p. S305.
92.Mancini, A., et al., Effects of testosterone on antioxidant systems in male secondary hypogonadism. J Androl, 2008. 29(6): p. 622-9.
93.Ghanbarzadeh, S., et al., Effects of L-carnitine and coenzyme q10 on impaired spermatogenesis caused by isoproterenol in male rats. Drug Res (Stuttg), 2014. 64(9): p. 449-53.
94.Lafuente, R., et al., Coenzyme Q10 and male infertility: a meta-analysis. J Assist Reprod Genet, 2013. 30(9): p. 1147-56.
95.Gava, A.L., et al., Effects of 5/6 nephrectomy on renal function and blood pressure in mice. Int J Physiol Pathophysiol Pharmacol, 2012. 4(3): p. 167-73.
96.Gonzales, G.F. and M. Zapana, Sperm motility should be assessed in fresh sperm and after a sperm washing procedure. Arch Androl, 1992. 28(2): p. 83-9.
97.Johnsen, S.G., Testicular biopsy score count--a method for registration of spermatogenesis in human testes: normal values and results in 335 hypogonadal males. Hormones, 1970. 1(1): p. 2-25.
98.Flurkey, K., J. Currer, and D. Harrison, The Mouse in Aging Research. The Mouse in Biomedical Research 2nd Edition, 2007.
99.Cosentino, M.J. and A.T. Cockett, Structure and function of the epididymis. Urol Res, 1986. 14(5): p. 229-40.
100.Koslov, D.S. and K.E. Andersson, Physiological and pharmacological aspects of the vas deferens-an update. Front Pharmacol, 2013. 4: p. 101.
101.Elmberger, P.G., et al., In vitro and in vivo synthesis of dolichol and other main mevalonate products in various organs of the rat. Eur J Biochem, 1987. 168(1): p. 1-11.
102.Kalen, A., et al., Ubiquinone biosynthesis by the microsomal fraction from rat liver. Biochim Biophys Acta, 1987. 926(1): p. 70-8.
103.Lippa, S., et al., Coenzyme Q10 levels, plasma lipids and peroxidation extent in renal failure and in hemodialytic patients. Mol Aspects Med, 1994. 15 Suppl: p. s213-9.
104.Xu, L.G., et al., Examination of the semen quality of patients with uraemia and renal transplant recipients in comparison with a control group. Andrologia, 2009. 41(4): p. 235-40.
105.Annuk, M., et al., Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol, 2001. 12(12): p. 2747-52.
106.Shayakhmetova, G.M., et al., Chronic alcoholism-mediated metabolic disorders in albino rat testes. Interdiscip Toxicol, 2014. 7(3): p. 165-72.
107.Nadjarzadeh, A., et al., Effect of Coenzyme Q10 supplementation on antioxidant enzymes activity and oxidative stress of seminal plasma: a double-blind randomised clinical trial. Andrologia, 2014. 46(2): p. 177-83.
108.Reddy, M.M., et al., Bacterial lipopolysaccharide-induced oxidative stress in the impairment of steroidogenesis and spermatogenesis in rats. Reprod Toxicol, 2006. 22(3): p. 493-500.
109.Diemer, T., et al., Reactive oxygen disrupts mitochondria in MA-10 tumor Leydig cells and inhibits steroidogenic acute regulatory (StAR) protein and steroidogenesis. Endocrinology, 2003. 144(7): p. 2882-91.
110.Crestanello, J.A., et al., Effect of coenzyme Q10 supplementation on mitochondrial function after myocardial ischemia reperfusion. J Surg Res, 2002. 102(2): p. 221-8.
111.Lee, B.J., et al., Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease. Nutrition, 2012. 28(3): p. 250-5.
112.Chao, C.T. and C.K. Chiang, Uremic toxins, oxidative stress, and renal fibrosis: an interwined complex. J Ren Nutr, 2015. 25(2): p. 155-9.
113.Maheshwari, R., et al., Effect of concomitant administration of coenzyme Q10 with sitagliptin on experimentally induced diabetic nephropathy in rats. Ren Fail, 2017. 39(1): p. 130-139.
114.Ferrari, B. and C. Kusano, Total Antioxidant Capacity : a biomarker in biomedical and nutritional studies. Journal of Cell and Molecular Biology 7, 2008: p. 1-15.
115.Quiles, J.L., et al., Life-long supplementation with a low dosage of coenzyme Q10 in the rat: effects on antioxidant status and DNA damage. Biofactors, 2005. 25(1-4): p. 73-86.
116.Stallons, L.J., R.M. Whitaker, and R.G. Schnellmann, Suppressed mitochondrial biogenesis in folic acid-induced acute kidney injury and early fibrosis. Toxicol Lett, 2014. 224(3): p. 326-32.
117.Granata, S., et al., Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genomics, 2009. 10: p. 388.
118.劉昌孝 and 孫瑞元, 藥物評價實驗設計與統計學基礎. 軍事醫學科學出版社, 1999.
119.Marín-García, J., Methods to Study Mitochondrial Structure and Function. Mitochondria and Their Role in Cardiovascular Disease, 2013.
120.DeLuca, M. and W.D. McElroy, Kinetics of the firefly luciferase catalyzed reactions. Biochemistry, 1974. 13(5): p. 921-5.
|